Clinical trial
Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT00176865 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00176865 |
|---|---|
| Title | Stem Cell Transplant for Immunologic or Histiocytic Disorders |
| Official title | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Immunologic or Histiocytic Disorders Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome, Griscelli Syndrome, Immunologic Deficiency Syndromes, Langerhans-Cell Histiocytosis |
| Intervention type | Drug, Procedure |
| Interventions | Stem Cell Transplant, Fludarabine, Melphalan, Anti-thymocyte globulin (ATG), Campath 1H, Cyclosporin A, Mycophenolate mofetil, Intravenous immunoglobulin (IVIG) |
| Enrollment | 19 |
| Start date | Aug 1, 2002 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2014 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: